Haemophilia: Blood Coagulation Pathways
34 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the most common type of hemophilia?

  • Hemophilia A (correct)
  • Hemophilia B
  • Hemophilia C
  • Von Willebrand disease

    • What is the mode of inheritance of hemophilia A and B?

  • X-linked recessive (correct)
  • Autosomal recessive
  • Mitochondrial inheritance
  • Autosomal dominant

    • What percentage of hemophilia cases are caused by new mutations?

  • 1/2
  • 3/4
  • 2/3
  • 1/3 (correct)

    • Which of the following is NOT a clinical presentation of hemophilia?

    <p>Hematemesis</p> Signup and view all the answers

    What is the deficiency in hemophilia C?

    <p>Factor 11</p> Signup and view all the answers

    What is the pathway that involves tissue factor (TF) and factor VIIa?

    <p>Extrinsic pathway</p> Signup and view all the answers

    What is the order of increasing concentration of clotting factors in the following treatment preparations?

    <p>Whole blood, plasma, cryoprecipitate, factor concentrates</p> Signup and view all the answers

    Which of the following is a complication of hemophilia?

    <p>All of the above</p> Signup and view all the answers

    What is the treatment for Factor XI deficiency?

    <p>Fibrinolytic inhibitor, Tranexamic acid, and factor XI concentrate</p> Signup and view all the answers

    Which of the following is a characteristic of Von Willebrand disease?

    <p>Autosomal dominant inheritance</p> Signup and view all the answers

    What is the role of VWF in the coagulation process?

    <p>Carrier for factor 8, platelets adhesion to vascular collagen</p> Signup and view all the answers

    Which population is more prone to Factor XI deficiency?

    <p>Ashkenazi Jews</p> Signup and view all the answers

    What is the primary goal of hemophilia therapy?

    <p>To treat and prevent bleeding episodes and related complications</p> Signup and view all the answers

    What is the benefit of regular prophylaxis in hemophilia therapy?

    <p>Reduced physical impairment from hemophilic arthropathy</p> Signup and view all the answers

    What is the target trough factor level in blood for standard prophylaxis regimens?

    <p>1-2%</p> Signup and view all the answers

    What is the purpose of immobilization of a limb in hemophilia treatment?

    <p>To relieve pain and stabilize the clot</p> Signup and view all the answers

    What laboratory investigation is normal in hemophilia?

    <p>Platelet number and function</p> Signup and view all the answers

    What is the purpose of factor assay in hemophilia diagnosis?

    <p>To measure the concentration of factors 8, 9, 11, and VWF</p> Signup and view all the answers

    What should be avoided in hemophilia treatment to prevent bleeding?

    <p>Surgical intervention or invasive diagnostic procedures</p> Signup and view all the answers

    What is the intrinsic pathway involved in?

    <p>Coagulation cascade</p> Signup and view all the answers

    What is the most common presentation of bleeding in females with Von Willebrand disease?

    <p>Menorrhagia and mucocutaneous bleeding</p> Signup and view all the answers

    What is the expected result of a Platelet function test in Von Willebrand disease?

    <p>Abnormal adhesion</p> Signup and view all the answers

    What is the purpose of Tranexamic acid in the treatment of Von Willebrand disease?

    <p>To inhibit fibrinolysis</p> Signup and view all the answers

    What is the underlying mechanism of Disseminated Intravascular Coagulation?

    <p>All of the above</p> Signup and view all the answers

    What is the characteristic finding on blood film examination in patients with Disseminated Intravascular Coagulation?

    <p>Red cell fragmentation</p> Signup and view all the answers

    What is the expected result of the Thrombin time test in patients with Disseminated Intravascular Coagulation?

    <p>Prolonged</p> Signup and view all the answers

    What is the primary indication for the use of Cryoprecipitate in patients with Disseminated Intravascular Coagulation?

    <p>Bleeding</p> Signup and view all the answers

    What is the percentage of patients with Disseminated Intravascular Coagulation who manifest thrombotic lesions?

    <p>5-10%</p> Signup and view all the answers

    What is the purpose of administering heparin or antiplatelet drugs to patients with thrombotic problems?

    <p>To inhibit the coagulation process</p> Signup and view all the answers

    Which of the following is an inherited thrombophilia?

    <p>Protein C deficiency</p> Signup and view all the answers

    What is the significance of a prolonged APTT in the investigation of thrombophilia?

    <p>It suggests the presence of an anticoagulant</p> Signup and view all the answers

    What is the mechanism of action of warfarin in the treatment of thrombophilia?

    <p>It inhibits the production of vitamin K</p> Signup and view all the answers

    What is a common side effect of heparin therapy?

    <p>Osteoporosis</p> Signup and view all the answers

    What is the significance of recurrent venous thrombosis in a young patient?

    <p>It is indicative of inherited thrombophilia</p> Signup and view all the answers

    Study Notes

    Haemophilia

    • Inherited coagulation factor defect, affecting 1 in 5,000 to 1 in 10,000 males
    • Three types: Haemophilia A (factor 8), Haemophilia B (factor 9), Haemophilia C (factor 11)
    • Von Willebrand disease (VWF) is also an inherited bleeding disorder

    Inheritance of Haemophilia

    • X-linked recessive disease, affecting males
    • 1/3 of cases develop post-new mutations, with no family history
    • Haemophilia A is the most common, with Haemophilia B accounting for 20% of cases

    Clinical Presentation

    • Petechiae, purpura, hematoma, joint bleeding, mucocutaneous bleeding, intracranial hemorrhage, post-tooth extraction bleeding, post-operative bleeding, trauma
    • Advanced joint and muscle bleeding

    Laboratory Investigation

    • Normal platelet count and function
    • Normal PT, PC, INR
    • Prolonged APTT
    • Factor assay (8, 9, 11, VWF)

    Treatment

    • "On-demand" or prophylaxis
    • Aimed at treating and preventing bleeding episodes and related complications
    • Regular prophylaxis started at an early age can reduce physical impairment from hemophilic arthropathy

    Complications of Haemophilia

    • Arthropathy, deformity
    • Muscle atrophy, nerve compression, limb ischemia
    • Fatal ICH bleeding
    • Pseudotumor (subperiosteal bleeding, new bone formation)
    • Infection (HCV, HBV, HIV) due to plasma product

    Factor XI Deficiency

    • Ashkenazi Jews, affects both sexes
    • Bleeding risk shows incomplete correlation to severity of deficiency
    • Treatment: fibrinolytic inhibitor (tranexamic acid), factor XI concentrate, or fresh frozen plasma

    Von Willebrand Disease

    • VWF carries factor 8, platelets adhere to vascular collagen
    • Most common inherited bleeding disorder
    • Autosomal dominant inheritance
    • Affects females, presenting with mucocutaneous bleeding
    • Menorrhagia, epistaxis, rare hemarthrosis, and muscle bleeding

    Laboratory Diagnosis

    • Normal CBC, normal PT, normal TT
    • Prolonged APTT
    • VWF antigen, activity
    • Factor 8 level (type III VWD)
    • Platelet function test abnormal adhesion

    Treatment

    • Supportive: avoid antiplatelets (aspirin), anticoagulants (warfarin), fibrinolytic inhibitor (tranexamic acid)
    • Cryoprecipitate, plasma, vasopressin (type 1 VWD)
    • VWF/factor 8 concentrate

    Acquired Coagulation Factors

    • Disseminated intravascular coagulation
    • Widespread inappropriate intravascular deposition of fibrin with consumption of coagulation factors and platelets
    • Associated with many disorders, e.g., leukemia, trauma, obstetric complications

    Clinical Presentation

    • Bleeding, thrombotic lesions, organ dysfunction
    • 5-10% of patients manifest thrombotic lesions

    Laboratory Investigation

    • Low platelet count
    • Low fibrinogen concentration
    • Prolonged thrombin time
    • High levels of fibrin degradation products (D-dimers) in serum and urine
    • Prolonged PT and APTT

    Treatment

    • Bleeding: supportive therapy with fresh frozen plasma and platelet concentrates
    • Thrombosis: heparin or antiplatelet drugs to inhibit coagulation process

    Thrombophilia

    • Inherited: anti-thrombin III, protein C deficiency, protein S deficiency, factor V Leiden
    • Acquired: dyslipidemia, malignancy, nephrotic syndrome, Behcet's syndrome, antiphospholipid antibody syndrome, pregnancy, COC, PNH, myeloproliferative disorder, leukemia

    Clinical Picture and Investigation

    • Recurrent venous thrombosis, abnormal site, young age
    • Arterial thrombosis, absence of arterial atherosclerosis
    • Recurrent abortion
    • Thrombophlebitis
    • Investigation: prolonged APTT, anticardiolipin antibody, lupus anticoagulant, level of protein S, C, anti-thrombin III, factor V Leiden

    Treatment

    • Anticoagulant: oral warfarin (vitamin K antagonist), parenteral heparin (subcutaneous, intravenous, unfractionated, low molecular weight)
    • Side effects: heparin-induced thrombocytopenia, osteoporosis

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the pathophysiology of haemophilia, including the intrinsic and extrinsic pathways of blood coagulation. Test your knowledge of the clotting factors and their interactions.

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser